COVID-19 TOPIC

Covaxin Tracker: An Overview of Development Progress

Around 200 research teams are working day and night on an effective COVID-19 vaccine.

Covaxin Development Progress

154

Pre-clinical

Not yet in human trials

44

Phase 1

Small-scale human trials

23

Phase 1/2

Combination of phases 1 and 2

12

Phase 2

Middle-scale human trials

10

Phase 3

Large-scale human trials

0

Approved

Authorization for general use

Source: WHO. Last updated 19 October 2020

Research teams around the globe are working day and night to develop an effective vaccine for COVID-19. However, vaccines generally take years of testing and research before being approved for general use. That's why researchers may pause their trials at any stage if they observe worrying symptoms in animals and human volunteers.

A vaccine can be either a weakened virus or parts of it. It prevents us from being infected with the actual virus by training our immune system to recognize and combat it. Please consult the World Health Organization (WHO)'s website for detailed information on individual vaccines in development.

Vaccine Testing Process

Related Stories

Worldwide COVID-19 Updates